XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Financial Condition - USD ($)
$ in Thousands
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
ASSETS        
Cash and cash equivalents $ 597,396 $ 158,337    
Securities available for sale, at fair value 1,480,090 1,741,221    
Securities held to maturity, at amortized cost (fair value $27,431 and $30,236, respectively) 32,001 33,092    
Federal Reserve Bank and Federal Home Loan Bank Stock, at cost 24,454 36,014    
Loans held for sale 72,648 691,688    
Loans and leases 4,562,681 4,075,195    
Allowance for credit losses (74,337) (71,765)    
Accrued interest receivable 35,279 31,385    
Premises, furniture, and equipment, net 38,263 39,055    
Rental equipment, net 206,754 205,339    
Goodwill and intangible assets 313,074 326,094    
Other assets 315,122 266,362    
Total assets 7,603,425 7,532,017 $ 7,902,511  
LIABILITIES        
Deposits 6,518,953 5,875,085    
Short-term borrowings 0 377,000    
Long-term borrowings 33,380 33,354    
Accrued expenses and other liabilities 293,538 424,389    
Total liabilities 6,845,871 6,709,828    
STOCKHOLDERS’ EQUITY        
Preferred stock, 3,000,000 shares authorized, no shares issued, none outstanding at December 31, 2024 and September 30, 2024, respectively 0 0    
Additional paid-in capital 640,422 638,803    
Retained earnings 313,446 337,058    
Accumulated other comprehensive loss (190,917) (153,394)    
Treasury stock, at cost, 70,215 and 3,769 common shares at December 31, 2024 and September 30, 2024, respectively (4,882) (249)    
Total equity attributable to parent 758,310 822,466    
Noncontrolling interest (756) (277)    
Total stockholders’ equity 757,554 822,189 $ 704,246 $ 618,347
Total liabilities and stockholders’ equity 7,603,425 7,532,017    
Common stock, $0.01 par value; 90,000,000 shares authorized, 24,189,631 and 24,851,122 shares issued, 24,119,416 and 24,847,353 shares outstanding at December 31, 2024 and September 30, 2024, respectively        
STOCKHOLDERS’ EQUITY        
Common stock 241 248    
Common stock, Nonvoting, $0.01 par value; 3,000,000 shares authorized, no shares issued, none outstanding at December 31, 2024 and September 30, 2024, respectively        
STOCKHOLDERS’ EQUITY        
Common stock $ 0 $ 0